Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,212 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ainos Inc | AIMD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 3.85% | 1.08 | 07:06:38 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.04 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 5 | 1,212 | - | 0.79 - 6.097 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:04:54 | 1 | US$ 1.02 | USD |
Ainos Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.19M | 5.95M | - | 122k | -13.77M | -2.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ainos News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.0202 | 1.08 | 1.00 | 1.04 | 30,250 | 0.0598 | 5.86% |
| 1 Month | 1.17 | 1.28 | 1.00 | 1.12 | 68,748 | -0.09 | -7.69% |
| 3 Months | 1.00 | 3.10 | 0.79 | 1.78 | 1,491,892 | 0.08 | 8.00% |
| 6 Months | 3.25 | 4.2899 | 0.79 | 2.04 | 971,329 | -2.17 | -66.77% |
| 1 Year | 3.90 | 6.097 | 0.79 | 2.38 | 544,782 | -2.82 | -72.31% |
| 3 Years | 18.60 | 18.75 | 0.79 | 4.65 | 552,634 | -17.52 | -94.19% |
| 5 Years | 18.60 | 18.75 | 0.79 | 4.65 | 552,634 | -17.52 | -94.19% |
Ainos Description
| Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company¿s products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. |
